A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function
PHASE1
This is a Phase 1 non-randomized, open-label, multiple dose, parallel-group...
A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
PHASE1
A multi-part study of ALG-097558 to evaluate safety, tolerability, pharmaco...
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
PHASE1
This is a Phase 1 non-randomized, open-label, multiple dose, parallel-group...